SLMy File
SLMy File
(PRESCRIBED BY NCISM)
Shalakya Tantra
(Ophthalmology, Oto-Rhino- Laryngology & Oro-Dentistry)
BOARD OF AYURVEDA
NATIONAL COMMISSION FOR INDIAN SYSTEM OF MEDICINE
NEW DELHI-110026
NCISM
III Professional Ayurvedacharya
(BAMS)
Subject Code : AyUG-SL
Shalakya Tantra
(Ophthalmology, Oto-Rhino- Laryngology & Oro-Dentistry)
Summary
Non-Lecture (NLHT)
60
Paper I 30
200(NLH)
Paper II 30
Non-Lecture (NLHP)
140
Paper I 70
Paper II 70
Paper II 100
Important Note :- The User Manual III BAMS is a valuable resource that provides comprehensive details about the
curriculum file. It will help you understand and implement the curriculum. Please read the User Manual III before
reading this curriculum file. The curriculum file has been thoroughly reviewed and verified for accuracy. However, if
you find any discrepancies, please note that the contents related to the MSE should be considered authentic. In case of
difficulty and questions regarding curriculum write to syllabus24ayu@[Link]
Course Code and Name of Course
SR1 A1 B1
CO Course learning Outcomes (CO) AyUG-SL Course learning
No At the end of the course AyUG-SL, the students should be able to- Outcomes mapped
with program
learning outcomes.
CO1 Demonstrate clincical application of anatomy and physiology of the Netra, Karna, PO1
Nasa, Mukha, Shiras.
CO3 Conduct appropriate clinical examinations using various diagnostic and imaging PO2,PO3
techniques, along with appropriate instrument usage and interpretation, as per
Ayurveda and contemporary medical sciences.
CO4 Present the cases related to Shalakyatantra with clinical reasoning (Naidanika PO2,PO5
Tarka) along with prognosis (Sadhya-asadhyata) in clinical practice.
CO5 Acquire a knowledge of principles of treatment and various therapeutic measures PO2,PO3,PO4,PO7
related to Shalakyatantra, according to Samhitas and contemporary medical
science.
CO6 Perform appropriate therapeutic measures related to Shalakyatantra and seek or PO4,PO7
refer for expert opinion whenever needed.
CO7 Communicate effectively with the patient, relatives and other stakeholders. PO7,PO8
CO8 Demonstrate ethics (Sadvritta), compassion (Karuna) and possess qualities of a PO6,PO7,PO9
clinician (Vaidyaguna).
Sr. A2 B2 C2 D2 E2 E2
No List of Topics Term Marks Lecture Non- Non-
hours Lecture Lecture
hours hours
Theory Practica
l
1 Shareera, Nidaana Panchaka of Netraroga. 1 30 2 2 6
E) Purvarupa of Netraroga.
F) Samprapti of Netraroga.
H) Classification of Netraroga.
B) Enumeration of Kriyakalpa.
C) Seka.
D) Pindi.
E) Vidalaka.
F) Aschyotana.
G) Tarpana
H) Putapaka.
I) Anjana.
4 Sanjnaharana in Netraroga. 1 0 1 0
5 Sandhigata Roga -1 1 3 0 2
A) Netrasrava (Epiphora).
B) Hyperlacrimation.
7 Sandhigata Roga -3 1 2 0 0
A) Krimigranthi (Blepharitis).
B) Parvani, Alaji.
8 Vartmagata Roga-1 1 34 4 1 6
A) Anjananamika (Hordeolum).
D) Pakshmashata.
E) Ectropion.
9 Vartmagata Roga-2 2 1 0 0
A) Pothaki (Trachoma).
B) Sikatavartma.
10 Vartmagata Roga -3 2 2 0 4
A) Vatahatavartma (Ptosis).
B) Nimesha.
C) Klinnavartma.
11 Bhedana Karma 2 0 1 2
12 Lekhana Karma. 2 0 1 2
13 Shuklagata Roga -1 2 3 0 6
A) Arma (Pterygium).
C) Shuktika.
D) Pishtaka.
14 Shuklagata Roga -2 2 2 0 2
15 Chhedana Karma. 2 0 1 2
17 Krishnagata Roga -1 2 5 0 4
C) Ajakajata (Staphyloma).
D) Sirashukla.
E) Akshipakatyaya.
18 Krishnagata Roga -2 2 2 0 4
B) Acute Iridocyclitis.(Tarakamandala-shotha.)
B) Eye Donation.
C) Corneal Transplantation.
21 Sarvagata Roga -1 2 18 4 1 2
A) Abhishyanda (Conjunctivitis).
B) Adhimantha.
C) Hatadhimantha.
22 Sarvagata Roga -2 3 3 1 2
B) Sashophapaka.
C) Ashophapaka.
D) Amloshita.
E) Sirotpaata.
F) Siraharshha.
G) Vaataparyaya.
H) Pillaroga.
23 Glaucoma 3 1 1 2
24 Drishtigata Roga-1 3 18 7 1 4
B) Amblyopia.
C) Kacha.
D) Linganasha.
F) Pitta-vidagdha Drishti.
G) Kapha-vidagdha Drishti.
H) Dhumadarshi.
I) Ushna-vidagdha Drishti.
J) Abhighataja Linganasha.
K) Sanimittaja Linganasha.
L) Animittaja Linganasha.
M) Gambhirika .
N) Hraswajadya.
O) Nakulandhya.
25 Nayanabhighata 3 1 0 2
26 Drishtigata Roga-2 3 1 1 2
27 Drishtigata Roga- 3 3 2 0 0
A) Dravyas in Netrachikitsa.
B) Swasthavritta in Netraroga.
C) Kuposhanajanya Netravikara
(Malnutritional Eye Disorders)
- Xerophthalmia.
- Xerosis.
Sr. A2 B2 C2 D2 E2 E2
No List of Topics Term Marks Lecture Non- Non-
hours Lecture Lecture
33 Karnaroga 1 1 2 0 2
A) Karnashoola (Otalgia).
B) Karna Shopha.
34 Nasa Shareera, Ghranendriya and Nidana 1 2 1 2
Panchaka of Nasaroga
35 Pratishyaya 1 3 1 0
A) Paribhasha of Mukha.
B) Mukha-Shareera.
37 Oshtharoga 1 10 1 0 0
38 Sarvasara Mukharoga 1 2 0 0
40 Kapalagata Roga 2 10 1 0 4
C) Noise pollution.
44 Karnakandu, Karnaguthaka, 2 2 0 4
Karnapratinaha, Krumikarna,
Karnavidradhi, Karnapaka.
45 Rhinitis 2 1 2 0
Rhinitis.
46 Deeptadi Nasaroga. 2 3 1 2
48 Dantamulagata roga 2 2 1 0
C) Dantanaadi.
49 Jihvagata Roga 2 1 1 0
A) Jihvakantaka (Glossitis).
Karnarbuda.
53 Karnasandhana 3 1 1 0
Karnasandhana (Auroplasty)
54 Bhraamara (Vertigo) 3 1 1 2
56 Nasarsha 3 1 1 2
60 Nasa-abhighata, Nasasandhana 3 1 0 2
61 Talugata Roga 3 2 1 0
A) Galashundika (Uvulitis)
B) Tundikeri
D) Gilayushotha (Tonsillitis)
E) Arbuda
F)Talushosha
G) Talupaaka
62 Kantharoga 3 4 2 6
A) Rohini
B) Kanthashaluka
C) Ekavrunda,Vrunda (Pharyngitis)
E) Maamsatana
F) Vidaari
H) Parotitis
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
Cour Learning Objective (At the end of the session, the Domai MK / Level T-L Assessmen Assess Ter Integra Type
se out students should be able to) n/sub DK / method t ment m tion
come NK Type
Topic 1 Shareera, Nidaana Panchaka of Netraroga. (LH :2 NLHT: 2 NLHP: 6)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO1 Define Paribhasha of Shalakya [Link] Netra Rachana CC MK KH L QZ ,VV-Vi F&S I V-RS,V- LH
Shareera (Anatomy of Eye). va,PUZ,M- RS
POS
CO1 Explain Kriya Shareera of Netra (Physiology of vision). CC MK KH D-M,PE CL- F&S I V-KS NLHT1.1
R,L&PP PR,COM
T ,TPW
CO1, Explain Classification of Netraroga according to treatment CC MK KH L&GD, P-POS,QZ , F&S I V-RN NLHT1.2
CO2 principles, prognosis, and Doshadhikya and Explain Saama- DIS T-
Nirama Lakshana. OBT,COM
CO2 Describe Samanya Hetus (Nija and Agantuja), Purvarupa, and CC MK KH BS,L&P M-CHT,V F&S I - LH
Samprapti of Netraroga. PT V-Viva,P-
EXAM
CO3, Perform History taking in cases of Netraroga. CAN MK SH PBL,ED Mini-CEX, F&S I - NLHP1.1
CO7 U,PT,T P-PRF,P-E
UT,D- XAM,P-
BED VIVA
CO3, Follow the steps in performing the structural examination of PSY- MK SH TUT,PT Mini-CEX F&S I - NLHP1.2
CO7 Netra. GUD ,D-BED
,D,CBL
CO5 Define, Describe types and dose, Indications and contra CK NK KH PER,FC PA,CR-RE F I - NLHT2.1
indications, Poorva, Pradhana and Pashchat Karma, Kala, Ayoga, ,L&GD D,T-CS,PR
CO6 Demonstrate Seka and [Link] informed consent and counsel PSY- MK SH D,D-M, P-PRF,DO F&S I - NLHP2.1
patients for Kriyakalpas in a simulated environment. MEC TUT,RP PS,DOPS,P
,TBL -EXAM,D
OAP
CO5 Define and Discuss Types and dose, indications and contra CC MK KH L&PPT PRN,M-CH F&S I - LH
indications, Poorva, Pradhana and Pashchat karma, Kala, Ayoga, ,L T,COM,QZ
Samyakyoga and Atiyoga Lakshanas, complications and ,VV-Viva
management of Tarpana and Putapaka.
CO5 List the key findings of current research on Tarpana and CK NK K DIS,TB CR-RED,M- F I - NLHT2.2
Putapaka. L,LS POS
CO6, Demonstrate Vidalaka and Aschyotana. PSY- MK SH D-M,T DOPS,P-P F&S I - NLHP2.2
CO7 MEC UT,SIM RF,DOPS,P
,D,PT P-Practical,
Log book
CO5 Summarise the steps involved in Tarpana and Putapaka. CC MK KH D-M,SI VV-Viva,P- F&S I - NLHP2.3
M,TUT, VIVA,O-
PT,D QZ
CO5 Define and Explain Types and Dosage, Indications and CC MK KH L&PPT T-CS,M-P F&S I - LH
contraindications, Poorva- Pradhana and Paschat karma, Kala, ,L OS,PRN,V
Heena, Samyaka and Atiyoga lakshanas, Complications of V-Viva,QZ
[Link] Anjana Shalaka.
CO5 List the key findings of current research on Anjana. CK NK K DIS,L& SA,CR- F I - NLHT2.3
GD,LS RED
CO5, Summarise the steps involved in Anjana. CC MK KH ML,SI VV-Viva,P F&S I - NLHP2.4
CO2, Describe etiology, clinical features, complications and medical CC DK KH L&PPT T-OBT F&S I - LH
CO5 management of acute and chronic Dacryocystitis.
CO3 Examine [Link] the steps in performing PSY- DK SH D-BED, OSCE,DOP F&S I - NLHP5.1
regurgitation test of the lacrimal sac and observe sac syringing. GUD D-M,RP S,P-EXAM,
,L_VC, DOPS,CH
CBL K
CO2, Explain etiology, clinical features, complications, and treatment CC DK KH L&PPT T-OBT,QZ F&S I - LH
CO5 of Ulcerative and Seborrhoeic [Link] clinical ,L
features and Chikitsasutra of Parvani; and clinical features of
Alaji.
CO2, Describe clinical features and management of Utsangini and CC MK KH L&PPT VV-Viva,T- F&S I - LH
CO5 [Link] the etiology, clinical features, and medical and CS
surgical management of Chalazion.
CO2, Describe etiology, clinical features, complications and principle CC NK KH L&PPT T-CS,VV- F&S I - LH
CO5 of treatment in [Link] clinical features and Viva
CO3, Discuss and Diagnose, Ectropion and Entropion. CAN DK KH DIS,PB CL-PR,QZ F I - NLHT8.1
CO5 L,TBL
CO3 Examine of Bhru (eyebrow), Pakshma (eye lashes), PSY- MK SH TUT,PB P-EXAM,P F&S I - NLHP8.1
Pakshmavartmasandhi (lid margin) and Vartma (eye lid). MEC L,L_VC -VIVA,OS
,D-BED CE
CO5 Summarise the steps involved in the incision and curettage (I&C) CC DK KH D,CBL, CHK,Log F I - NLHP8.2
for treating a Chalazion. L_VC book,OSCE
CO3, Demonstrate assessment of Pakshmakopa (Trichiasis / Entropion) PSY- DK SH D-BED, SP,Mini- F&S I - NLHP8.3
CO4, and [Link] misdirected eyelash removal by GUD L_VC,P CEX,OSCE
CO7 Epilation. BL,ML
CO3, Present an appropriate history in a patient with complaints of CAP DK KH PBL Mini-CEX F&S II - NLHP10.1
CO4, Abnormal Eyelid Mobility.
CO6,
CO7
CO2, Describe clinical features and management of Klinnavartma and CC NK KH L&PPT VV-Viva,T- F&S II - LH
CO5 Utklishtavartma. CS
CO5, Participate in the team for Bhedana Karma in Netraroga. PSY- MK SH L_VC,C Log book,T F II - NLHP11.1
CO7 PER BL,D,T R,CHK
UT
CO5, Participate in the team for Lekhana Karma in Netraroga. PSY- MK SH D,TUT, CHK,TR,L F II - NLHP12.1
CO7 PER L_VC,P og book
BL
CO2, Describe Medical management and Surgical excision of Arma CC MK KH L&PPT VV-Viva,T- F&S II - LH
CO5 (Pterygium).[Arma Chhedana, Conjunctival limbal autograft or CS
amniotic membrane graft with Its indications, contra-indications,
type of anaesthesia, major surgical steps and post-operative care.]
CO3, Present an appropriate history in patients presenting with growth AFT- MK SH PBL,D- Mini-CEX F&S II - NLHP13.2
CO2, Describe clinical features and management of [Link] CC MK KH L&PPT T-CS,VV- F&S II - LH
CO5 etiology, clinical features and management of Sub-Conjunctival Viva
[Link] clinical features and management of
Shuktika and Pishtaka.
CO3, Present an appropriate history in a patient presenting with a AFT- MK SH CBL,PB Mini-CEX F&S II - NLHP13.3
CO4, Raktaakshi (Red Eye) - Arjuna (Sub-Conjunctival Haemorrhage). RES L,D-
CO6, BED
CO7
CO2, Describe etiology, clinical features and treatment of Episcleritis CC MK KH L&PPT T-CS,VV- F&S II - LH
CO5 and Scleritis. Viva
CO3, Present an appropriate history in a patient presenting with AFT- MK SH CBL,D- Mini-CEX F&S II - NLHP14.1
CO4, Raktaakshi (Red Eye) - Sirajala / Sirajapidaka (Episcleritis and RES BED
CO6, Scleritis - Diffuse / Nodular); differentiate nodule at limbus.
CO7
CO5 Participate in the team for Chhedana in Netraroga. PSY- MK SH CBL,L_ TR,Log F II - NLHP15.1
PER VC,D book,CHK
CO2, Describe etiology, clinical features, types, prognosis and CC MK KH L,L&PP T-OBT,VV- F&S II - LH
CO5 management of Avrana Shukra (Corneal Opacity).. T Viva
CO2, Describe Etiology, Clinical features and Treatment of CAN MK KH L&PPT VV-Viva,T- F&S II - LH
CO5 Ajakajata.(Anterior Staphyloma) OBT
CO2, Explain clinical features and treatment of Sirashukla and clinical CC DK KH L&PPT T-OBT,VV- F&S II - LH
CO5 features of Akshipakatyaya. ,L Viva,QZ
CO3, Present the method of examination of a Sashula AFT- MK SH SIM,D- P-EXAM,O F&S II - NLHP17.1
CO3, Summarise the steps involved in the technique of Slit lamp CC MK KH ML,TU PP- F&S II - NLHP17.2
CO7 examination. T,D,PB Practical,SP
L,SIM
CO1, Recap Applied anatomy of [Link] and narrate (Anatomical CAP MK KH L&PPT VV-Viva,T F&S II - LH
CO2 and Etiological) classification of Uveitis. ,L -OBT,M-
POS
CO5 Explain the indications, contraindications, dosage and untoward CC NK KH RP,ML, VV- F&S II - NLHT19.2
effects of Anti-inflammatory agents (Ketorolac,Flurbiprofen), and PBL,BL Viva,QZ
Steroids ( Dexamethasone and Prednisolone) used in ,FC
Ophthalmology.
CO5 Explain the indications, contraindications, dosage and untoward CC NK KH RP,DIS, PA,VV- F&S II - NLHT19.3
effects of Antibiotics (Bacitracin, Moxifloxacin, Tobramycin, LS,ML, Viva,QZ
Gentamycin), antifungal agents PER
(Amphoterecin,Natamycin,Fluconazole), and antiviral agents
(Trifluridine, Acyclovir).
CO2, Explain the indications, contra indications, dosage and untoward CC DK KH FC P-EXAM,C F&S II - NLHT19.4
CO5 effects of lubricating agents and artificial tears (CMC,HPMC, L-PR,QZ
Carbomers, Poly-vinyl Alcohol and Acetylcysteine).
CO5 Explain the Objectives, Awareness & Significance of Eye CC NK KH L&GD, VV-Viva,M- F&S II - NLHT20.2
donation. BS POS,CL-
PR
CO5 Enlist types; describe indications, techniques, risks and CC NK KH DIS,L& QZ ,M-POS F&S II - NLHT20.3
complications of corneal transplantation. PPT ,VV-Viva
,L_VC
CO2, Explain National Programme for Control of Blindness. CC DK KH FC,PER QZ ,CL-PR F&S II - NLHT20.4
CO5 ,PRN,M-
POS
CO2 Give Etiological and Clinical Classification, Clinical features CC MK KH L,L&PP T-CS,T-OB F&S II - LH
(Bacterial, Viral &Allergic) and differential Diagnosis T T,VV-Viva
of Conjunctivitis.
CO2, Describe Management and complications of Conjunctivitis. CC MK KH PBL,LS CL-PR,T- F&S II - NLHT21.1
CO5 ,FC,BL OBT,QZ
CO2, Explain Hetu, Lakshana, Chikitsa and Upadrava of different types CC MK KH L&PPT T-OBT,VV- F&S II - LH
CO5 of Adhimantha and Hatadhimantha. Viva,QZ ,T-
CS
CO3, Present a case of Raktaakshi (red eye) presenting with Srava AFT- MK SH D,PBL, P-PRF,Mini F&S II - NLHP21.1
CO4, (discharge). RES TUT,RP -CEX,P-VI
CO7, VA,OSCE
CO8
CO2, Construe Lakshanas and Chikitsa of Sashophapaka, Ashophapaka, CC DK KH L,L&PP QZ ,T-OBT F&S III - LH
CO5 Amloshita, Sirotpata, Siraharsha, and Vataparyaya. T ,T-CS,PUZ,
VV-Viva
CO2, Enlist the diseases mentioned in Pillaroga, And describe Nidana CC NK KH PL,DIS, VV-Viva,C F&S III - NLHT22.1
CO5 and Chikitsa of Pillaroga. BL,TBL L-PR,QZ
,TPW
CO3, Present a case presenting with Shushkakshi (dry eyes). AFT- MK SH SIM,TU OSCE,Mini F&S III - NLHP22.1
CO4, RES T,ML,P -CEX,P-EX
CO7, BL,CD AM,P-VIV
CO8 A,P-CASE
CO5 Describe fundamentals of surgical techniques for Management of CC NK KH BL,L_V QZ ,M- F&S III - NLHT23.1
Glaucoma (Peripheral Iridectomy, Trabeculectomy, C,ML POS,CHK
and cyclodestructive procedures).
CO3, Summarize the steps involved in the technique of Tonometry and CC MK KH D-BED, QZ ,P- F&S III - NLHP23.1
CO7 Perimetry. PBL,TU EXAM,SP
T,D-M
CO2, Elaborate clinical features and management of Doshaja Timira. CC MK KH L,L&PP T-OBT,VV- F&S III - LH
CO5 T Viva
CO2, Explain Clinical features and Treatment of Kacha CC MK KH L&PPT T-OBT,M- F&S III - LH
CO5 and Linganasha. ,L POS,CL-
PR
CO5 Narrate Kaphaja Linganasha Shastrakarma- Poorva , Pradhana, CC MK KH L&PPT CL-PR,QZ F&S III - NLHT24.1
Pashchat karma; Vedhana Shalaka; Upadravas. ,FC,DIS
CO2, Define and expound etiological and clinical classification, clinical CC MK KH L&PPT VV-Viva,T- F&S III - LH
CO5 features, complications and treatment of errors of refraction - ,L OBT
(Myopia, Hypermetropia, Astigmatism).
CO2, Define, Describe etiology, clinical features and treatment of CC DK KH L,L&PP T-OBT,QZ F&S III - LH
CO5 Presbyopia and Amblyopia. T ,VV-Viva
CO2, Detail Clinical features and Treatment of Pitta-vidagdha Drishti, CC DK KH L,L&PP T-OBT,VV- F&S III - LH
CO5 Kapha-vidagdha Drishti, Dhumadarshi and Ushna-vidhagdha T Viva
Drishti.
CO2, Describe the clinical features of Abhighataja Linganasha, CC DK KH L,L&PP QZ ,VV-Vi F&S III - LH
CO5 Sanimittaja Linganasha, Animitta Linganasha, Gambhirika and T va,T-OBT
[Link] the clinical features and treatment of
Nakulandhya.
CO3, Demonstrate the technique of Fundus examination. PSY- MK SH ML,D,P QZ ,SA F&S III - NLHP24.1
CO3, Present an appropriate history in a patient with Timira (Dimness AFT- MK SH PBL,CD P-EXAM,O F&S III - NLHP24.2
CO4, of vision). RES ,RP,D,S SCE,P-
CO6, IM VIVA
CO7
CO5, Summarize the steps involved in the technique of removal of CC MK KH BS,ML, P-MOD,D F&S III - NLHP25.1
CO6, Agantuja Shalya from the eye. SIM,D- OPS,DOPS
CO7, M,DIS
CO8
CO2, Enlist procedures for surgical management of Senile CC NK K L_VC,D OSCE,QZ , F&S III - NLHT26.1
CO5 [Link] Small Incision Cataract Surgery (SICS) and IS,L&G VV-
Phacoemulsification (Their indications, contraindications, type of D,ML Viva,COM
anesthesia, major surgical steps, post-operative care,
complications, and their management in brief).Summarise current
research studies on Kaphaja Linganasha/Timira (Cataract).
CO3, Demonstrate the technique of ocular examination in a patient with AFT- MK SH D,D-BE P-VIVA,O F&S III - NLHP26.1
CO7 Cataract. RES D,ML,P SCE,360D,
BL,CD PP-
Practical
CO2, Define, describe etiopathology, clinical features, complications CC DK KH L&PPT VV-Viva,T- F&S III - LH
CO5 and treatment of -Jarajanya Pitabindu Upaghata (Age-related ,L OBT
macular degeneration) and Drishti-nadi Shosha (Optic Atrophy).
CO2, Present a case of Madhumehajanya Drishtiroga (Diabetic AFT- MK KH ML,PB VV- F&S III - NLHP27.1
CO5, Retinopathy). RES L,D- Viva,OSCE
CO7 BED
Topic 29 Dravyas used in Netra Chikitsa-3, Swasthavritta, Kuposhanajanya Netravikara (Malnutritional Eye Disorders), Community Ophthalmology.
(LH :1 NLHT: 3 NLHP: 8)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO5, Identify and describe Guna,Karma and Matra of Samanya CC MK KH D,DG P-EXAM,P- F&S III - NLHP29.1
CO6 Chakshushya Dravyas. ID
CO5 Observe the communication between physician and patient CC DK KH Log book F III - NLHP29.2
regarding prescription (Matra, Anupana, Route of administration,
Untoward effects) of Samanya Chakshushya Yoga.
CO5 Describe Netra Swasthyahitakara Dinacharya. CC MK KH DIS,LS, VV-Viva,C F&S III - NLHT29.1
BL OM,CL-PR
CO5 Describe Netra Swasthyahitakara Aahara Evam Vihara. CC DK KH LS,DIS, CL-PR,VV- F&S III - NLHT29.2
PER Viva,QZ
CO5 Describe causes, clinical features, prevention and treatment of CC DK KH FC,DIS QZ ,VV- F&S III - NLHT29.3
Naktandhya (Night Blindness); and Jeevanasatwa-Kshayajanya Viva,PRN
Netraroga (Vitamin deficiency disorders)(Malnutritional Eye
disorders)- (Deficiency of Vitamin-A, Vitamin-B1, Vitamin- B2,
Vitamin C, Vitamin-D).
CO4, Present an appropriate history in a patient presenting with AFT- MK KH SIM,RP OSCE,Log F&S III - NLHP29.3
CO7 Naktandhya (night blindness). RES ,PBL book,QZ
CO2, Describe the etiology, clinical features, WHO Classification, CC NK KH L&PPT VV-Viva,T- F&S III - LH
CO5 management and prophylaxis of Xerophthalmia. Describe clinical ,L OBT
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
Cour Learning Objective (At the end of the session, the Domai MK / Level T-L Assessmen Assess Ter Integra Type
se out students should be able to) n/sub DK / method t ment m tion
come NK Type
Topic 30 Enumeration, Nidana Panchaka and Sadhya-asadhyata of Shiroroga (LH :2 NLHT: 1 NLHP: 4)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO1, Classify Shiroroga according to Sushrutha and [Link] CC MK KH L&PPT QZ ,P-VIV F&S I - LH
CO2, Sadhya-asadhyatwa of [Link] the Samanya Nidana ,L A,T-OBT,
CO5 and Samprapti of [Link] Hetus, Lakshana, Chikitsa of M-POS,S-
Vataja Shiroroga, Pittaja Shiroroga, Kaphaja Shiroroga and LAQ
Sannipataja Shiroroga.
CO2, Present an appropriate history in a patient presenting with AFT- MK SH CD,D,T P-EXAM,P F&S I - NLHP30.1
CO5, Shirahshoola. Learn Differential diagnosis of Shirorogas -Vataja, RES UT,PBL -VIVA,SA,
CO7 Pittaja, Kaphaja, Sannipataja, Suryavartha, Anantavata, ,RP OSCE
Ardhavabhedhaka.
CO2, Understand the International Classification of Headache ICHD-3 CC DK KH LS,L&P M-POS,CL- F&S I - NLHT30.1
CO5 and discuss Samanya Yogas used in Shiroroga. PT PR
,DIS,SY
CO2, Perform History taking and give outline of case sheet (Shira CAP MK SH BL,RP, SP F&S I - NLHP30.2
CO7 Karna Nasa Mukha roga). D,TUT,
PBL
CO2, Present an appropriate history in a patient presenting with AFT- MK SH CD,RP, SA,PP-Prac F&S I - NLHP31.2
CO3, Ardhavabhedaka. RES PBL,D- tical,OSCE
CO3, Discuss Ardhabhedaka, Anantavata and Suryavarta. CC MK KH DIS,PE PP-Practica F&S I - NLHT31.2
CO5 R l,INT,CL-
PR
Topic 32 Karna Rachana Shareera, Nidana Panchaka and Samanya Chikitsa of Karnaroga (LH :2 NLHT: 2 NLHP: 4)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO1, Define Karna Nirukti, Karna Shareera (Asthi, Sandhi, Peshi, Sira, CK MK K L,L&PP M-POS,DE F&S I - LH
CO2 Marma) and Shravanendriya, Enlist Karna Rogas,Explain T B,PRN,T-O
Samanya Nidana, Samanya Samprapti and Describe Samanya BT,S-LAQ
Chikitsa of Karna Roga.
CO1 Describe the anatomy of different structures of Karna - Ear CC MK KH L&PPT P-VIVA,P F&S I V-RS,V- NLHT32.1
(External, Middle, and Internal) and clinical application. ,PER,M UZ,PRN,S- RS
L,L_VC LAQ,VV-
,DIS Viva
CO1, Elaborate Karna Roga- Samanya Nidana, Samanya Samprapti CC MK K L&PPT P-REC,VV- F&S I V-RN NLHT32.2
CO2, and Sadhya-asadhyata. ,LS,L& Viva,M-PO
CO4, GD,DIS S,T-OBT,C
CO5 ,SDL L-PR
CO3, Examination of [Link] the use of a headlamp and PSY- MK SH PT,TUT P-ID,Log F&S I - NLHP32.1
CO7 otoscopy in the examination of Karna, Nasa and Mukha (Ear, GUD ,TBL,R book,P-
Nose and Throat). P,ML PRF
CO2, Present an appropriate history in a patient presenting with AFT- MK SH X-Ray,P PP- F&S I - NLHP33.1
CO3, Karnashoola (Otalgia). RES BL,CD, Practical, C
CO4, RP,PT -VC,OSCE,
CO5, P-RP,P-
CO7 EXAM
Topic 34 Nasa Shareera, Ghranendriya and Nidana Panchaka of Nasaroga (LH :2 NLHT: 1 NLHP: 2)
CO3, Describe Nasya in Diseases described in CC DK KH DIS,FC, M-CHT,CL F&S I H-PK NLHT34.1
CO5 [Link] current research studies on Nasya and TBL,LS -PR,M-
Dhumapana in the diseases of Shira, Karna, Nasa, and Mukha. POS,QZ
,VV-Viva
CO2, Explain Upadrava, Sadhyasadhyata and Chikitsa of Pratishyaya. CC MK KH L,L&PP VV-Viva,T- F&S I - LH
CO5 Elaborate Nidana, Samprapti, Lakshanas and Chikitsa of T OBT,QZ
Dushtapratishyaya.
CO2, Discuss Nidana, Samprapti, Lakshanas and Chikitsa of Puyarakta, CC MK KH DIS,PL, T-OBT,P-P F&S I - NLHT35.1
Topic 36 Mukha Shareera and Nidana Panchaka of Mukharoga (LH :1 NLHT: 1 NLHP: 4)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO1 Define Paribhasha of Mukha, Describe the anatomy of Ostha CC MK KH LS,DIS, CL-PR,QZ F I V-RS,V- NLHT36.1
(lips), Mukha-kuhara (oral cavity), Jivha(tongue), Danta (teeth), FC,ML RS
Gala- Talu (Pharynx), Lalagranthi -Salivary glands (parotid,
submandibular) and Swarayantra (larynx).
CO3, Present an appropriate history in a patient presenting with an Oro AFT- MK SH PBL,D- P-EXAM,P F I - NLHP36.1
CO7, – dental complaint. RES BED,RP -CASE,OS
CO8 ,TUT CE,SP,C-
INT
CO2, Explain the etiology, clinical features and treatment of Oral CC NK KH L&PPT T-OBT,QZ F&S I - LH
CO5 submucous fibrosis, and Tumours of the oral cavity, (Pleomorphic ,T-CS,INT,
adenoma, Malignancies of tongue, palate and oral mucosa). M-CHT
CO3, Decipher the steps involved in Prachchhana, and CC DK KH D,PT CHK,VV-V F&S II - NLHP40.1
CO7 Jalaukavacharana. iva,M-POS
CO3, Summarise the steps involved in performing Agnikarma in CC DK KH PT,D,P DOPS,P-VI F&S II - NLHP40.2
CO7 Shiroroga/Kapalagata Roga. ER VA,DOPS,
CL-PR
Topic 42 Karna Badhirya, Karna Naada and Kshweda (LH :3 NLHT: 1 NLHP: 12)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO2, Describe Hetu, Samprapti, Lakshanas and Chikitsa of Karna CC MK KH BL,L&P T-OBT,CL- F&S II - LH
CO3, [Link] types of Hearing Loss (Conductive, PT PR,DEB,P-
CO5 Sensorineural and Mixed) and its investigations (Tunning Fork ,L,PER EXAM,PP-
Test, Audiometry, Impedance Audiometry).Summarise Etiology, Practical
Pathology, Differential Diagnosis of Otosclerosis, Medical and
Surgical Management of Otosclerosis.
CO2, Explain Hetus, Lakshanas, Samprapti and Chikitsa of Karna CC MK KH L,L&PP QZ ,S-LAQ F&S II - LH
CO3, Naada, Karna [Link] types and Causes, Investigation T ,PP-Practic
CO5 and Treatment of Tinnitus. al,CL-PR,P-
VIVA
CO7 Describe the National Program for Prevention and Control of CC DK K RP,BL P-RP,M-PO F&S II - NLHT42.1
[Link] Causes and ill effects of Noise Pollution. S,VV-Viva
CO2, Present an appropriate history in a patient presenting with AFT- MK SH L_VC,R P-CASE,V F&S II - NLHP42.1
CO3, Badhirya (Deafness). RES P,PBL, V-Viva,OS
CO4 D-BED, CE,Mini-
TUT CEX
CO3, Demonstrate the technique of Tuning fork Tests. PSY- MK SH TUT,C DOPS,VV- F&S II - NLHP42.2
CO4, MEC D,RP,D, Viva,CL-P
CO5 PBL R,PP-Practi
cal,DOPS
CO2, Present an appropriate history in a patient presenting with Karna AFT- MK SH PT,D-B QZ ,P-CAS F&S II - NLHP42.4
CO3, Kshweda- Naada (Tinnitus)- RES ED,CD, E,P-PRF,P-
CO4 PBL,TU VIVA,S-
T LAQ
CO3, T -Practical,T
CO4, -CS,P-CAS
CO5 E,P-EXAM
CO2, Present appropriate history in a patient presenting with Karna AFT- MK SH RP,D-B Log book,P F&S II - NLHP43.1
CO3, Srava (Otorrrhoea) RES ED,ML, -RP,P-VIV
CO4, LS,CD A,P-EXAM
CO5 ,VV-Viva
CO2, Explain Samprapti, Lakshanas and Chikitsa of Putikarna. CC MK KH LS,PBL T-OBT,P-E F&S II - NLHT43.1
CO3, ,ML,L& XAM,CL-P
CO5 GD R,P-VIVA,
VV-Viva
CO1, Elucidate Etiology, Pathology, Clinical Features and Management CC MK KH L,L&PP COM,P-EX F&S II - LH
CO2, of Acute Suppurative Otitis Media (ASOM)Expound Etiology, T AM,CL-PR
CO3, Pathology, Clinical Features and Medical Management of Safe ,S-LAQ,T-
CO4, Chronic Suppurative Otitis Media (Safe CSOM), Unsafe Chronic CS
CO5, Suppurative Otitis Media (Unsafe CSOM) and Serous Otitis
CO6 Media (SOM).Enumerate Complications of Otitis
[Link] the Etiology, Pathology, Clinical Features, and
Medical Management of Mastoiditis.
CO1, Explain Indications, Contra-Indications, Types and Basic Surgical CC MK KH L_VC,D P- F&S II - NLHT43.2
CO2, Steps in Tympanoplasty. -M,BL, EXAM,QZ
CO3, RP,PBL ,VV-
CO4, Viva,OSCE
CO5
CO2, Present an appropriate history in a patient presenting with Karna AFT- MK KH PBL,TU P-CASE,P- F&S II - NLHP44.1
CO3, Kandu. RES T,ML,D- EXAM,P-P
CO4, BED RF,Mini-
CO5 CEX
CO1, Describe Samprapti, Lakshanas, Upadravas and Chikitsa of Karna CC MK KH L&PPT PP-Practica F&S II - LH
CO2, Guthaka (Ear Wax).Explain Samprapti, Lakshanas and Chikitsa ,L l,T-OBT,V
CO3, of Karna Pratinaha and Krimikarna (Maggots in Ear).Decipher V-Viva,CL-
CO4, Hetu, Lakshanas, Samprapti and Chikitsa of Karna Vidradhi, PR,QZ
CO5, Karnapaaka (Otitis Externa).
CO6
CO1, Summarise the technique for removal of Karnaguthaka (ear wax) CC MK KH TUT,PB Log book,P F&S II - NLHP44.2
CO3, from the ear. L,D- -CASE,P-
CO5, BED VIVA
CO6
CO2, Describe Differential Diagnosis, Investigations, Complications, CC MK KH LS,L& QZ ,INT,V F&S II - NLHT45.1
CO5 and Treatment of Acute Non-specific Rhinitis (The common GD,DIS V-
cold).Explain Differential Diagnosis and Treatment of Chronic ,FC Viva,PRN
Hypertrophic Rhinitis.
CO3, Present an appropriate history in a patient presenting with AFT- MK SH D-BED, OSCE,Mini F&S II - NLHP46.1
CO4, Nasasrava (Rhinorrhoea), Sinusitis. RES CD,PBL -CEX,P-
CO7 VIVA,CBA
CO2, Describe Samprapti, Lakshana and Chikitsa of Deepta, Putaka, CC MK KH L&PPT COM,PRN, F&S II - NLHT46.1
CO5 Nasaparishosha, Bhramshathu, Nasanaha, Kshavathu. ,RP,FC, SA,P-VIV
ML,DIS A,VV-Viva
Septum).
CO2, Describe the clinical features and treatment of Paridara, CC MK KH L&PPT T-OBT,PU F&S II - LH
CO5 Adhimamsa (Impacted wisdom tooth), and Describe the Nidana, Z,M-
Samprapti, clinical features, classification and treatment of POS,QZ
DantaNaadi.
CO2, Describe the clinical features and treatment of Sheetada, CC MK KH ML,FC, P-VIVA,M- F&S II - NLHT48.1
CO5 Upakusha, Dantaveshtaka and Dantavidradhi(Apical abscess). PBL,L& POS,CL-
GD,PL PR,QZ
CO2, Describe the clinical features and management of ankyloglossia CC MK KH FC,PL, VV-Viva,P- F&S II - NLHT49.1
CO5 and glossitis (Hairy tongue, Geographic tongue, Migratory ML,DIS VIVA,QZ ,
Glossitis). ,LS M-POS,CL-
PR
Topic 51 Dravyas used in Karna Nasa Mukha Roga Chikitsa-1 (LH :1 NLHT: 0 NLHP: 2)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO5 Elucidate Common Dravyas used in Karna Nasa Mukha CC DK KH L INT,O-QZ, F&S II - LH
Roga- Antibiotics, PPIs, Steroids, Antihistamines, Nasal P-EXAM,V
Decongestants, and Anesthetic drugs. V-
Viva,PUZ
CO5, Describe Samanya Yoga (Drugs) used in Karna Nasa Mukha CC DK KH D,DA,L COM,CBA, F&S II V-DG NLHP51.1
CO7 Roga. &GD,D Log book,I
IS,CBL NT,P-ID
CO3, Elaborate on Indications, Contraindications, and Surgical CC DK KH SIM,FC C-VC,OSC F&S III - NLHT53.1
CO4, procedures of Auroplasty. ,D-M,P E,CL-
CO5 BL,L_V PR,QZ ,M-
C POS
CO1, Describe Etiology, Pathology, Clinical Features and Management CC DK KH L&GD, M-POS,DO F&S III - NLHT54.1
CO2, of Benign Paroxysmal Positional Vertigo (BPPV) ML,FC, AP,CL-
CO3, L&PPT PR,QZ ,T-
CO4, ,PER OBT
CO5,
CO6
CO2, Describe Types, Clinical features and method of removal of CC DK KH TUT,L P-CASE,C F&S III - NLHT55.1
CO5 Agantuja Shalya (Foreign Body) in Ear. &PPT , L-PR
PT,L_V
C,TBL
CO5 Expound surgical treatment of Nasal Polyps. (FESS surgery- CC DK KH L_VC, CHK,VV- F&S III - NLHT56.1
indications, contraindications, type of anesthesia, major surgical ML Viva,QZ
steps, post-operative care, complications and their management in
brief)
CO5 Describe Management of Nasagata Raktasrava (Epistaxis). CC MK KH L_VC,D- P-MOD,V F&S III - NLHT57.1
M,RP V-Viva,T-
OBT
CO3, Present cases with Nasagata [Link] the steps AFT- MK SH D-M,D- 360D,P-VI F&S III - NLHP57.1
CO5, involved in the Atyayika Chikitsa in Nasagata Raktasrava RES BED,PB VA,OSCE
CO6 (Anterior epistaxis). L
CO2, Describe investigations and treatment for Nasarbuda- Tumors of CC DK KH FC,DIS, M-POS,CL- F&S III - NLHT58.1
CO5 nose and paranasal sinuses. (Rhinophyma and Squamous cell PER PR
Ca).
CO3, Describe the etiology and types of Agantuja Shalya (Foreign CC MK KH TUT,X- P-EXAM,P F&S III - NLHP59.1
CO5, Body) in Nasa (nose), and their Clinical Features, Common Ray,CD P-Practical,
CO7 locations and complications, investigations, and treatment. ,SIM P-VIVA
CO5, Summarise the steps involved in Nasasandhana Vidhi as CC MK KH SIM,TU CHK,P-EX F&S III - NLHP60.1
CO6 explained by Sushruta. T,D-M AM,M-CH
T,DOPS,D
OPS
CO2, Describe Etiology, Clinical Features and Treatments of CC DK KH L&PPT OSCE,PRN F&S III - LH
CO5 Ekavrunda, Vrunda, Gilayu, Galavidradhi (peritonsillar abscess), ,L
Mamsatana and Vidari.
CO2, Present the case of a patient presenting with Geelana-Shoola AFT- DK SH D,L&G P-EXAM,P F&S III - NLHP62.1
CO3, (Odynophagia), Geelana-kashta (Dysphagia), and Mukha RES D,CBL -VIVA,CB
CO5, Dourgandhya (Halitosis). A,OSCE
CO7
CO2, Present cases of Ekavrunda, Vrunda (Pharyngitis), Gilayu, AFT- DK SH TUT,PB OSCE,P- F&S III - NLHP62.2
CO3, Galavidradhi, Rohini and Kanthashalooka. RES L,D- ID,CL-PR,
CO5, BED C-VC,P-
CO7 CASE
CO2, Present an appropriate history in patients presenting with AFT- DK SH D-BED, P-RP,P-EX F&S III - NLHP62.3
CO3, Swarabheda (Hoarseness of voice) and Kantha Koojana (Stridor). RES TBL,CB AM,Mini-
CO5, L,TUT, CEX,OSCE
CO7 CD
CO2, Explain the etiology, clinical features, and treatment of CC DK KH L&GD, P- F III - NLHT62.2
CO5 Galavidradhi. (Peritonsillar abscess, Paratonsillar abscess, Para FC EXAM,QZ
and Retropharyngeal abscess) ,PRN
Topic 63 Dravyas used in Karna Nasa Mukha Roga Chikitsa-2 (LH :1 NLHT: 1 NLHP: 2)
A3 B3 C3 D3 E3 F3 G3 H3 I3 K3 L3
CO5 Discuss Samanya Yogas used in Shiro Karna Nasa Mukha Roga. CC DK KH REC,L QZ ,P-VIV F&S III - NLHT63.1
&GD,B A,COM
L,PL
CO5, Discuss prescription of Samanya Yogas used in Shiro Karna Nasa CC DK KH DIS P-EXAM,P F&S III V-RS,V- NLHP63.1
CO7 Mukha Roga. -CASE,SP, RS
VV-Viva
Sr. A B
No List of Topics Marks MCQ SAQ LAQ
1 Shareera, Nidaana Panchaka of Netraroga. 30 Yes Yes No
Sr. A B
No List of Topics Marks MCQ SAQ LAQ
30 Enumeration, Nidana Panchaka and Sadhya-asadhyata of 10 Yes Yes No
Shiroroga
1 30
Long case assessment
2 10
Short case assessment (One case)
* No history is taken.
* Following the examination the candidate must give a 3-5 minute summary of
* A smooth and confident technique and a gentle, kind and friendly manner
indicate professionalism.
5 10
Journal or Case Record Viva
Probe the reasoning behind the chosen treatment and its expected outcomes.
Present alternative scenarios and ask students how they would adapt their
diagnosis or management plan.
Assess the accuracy, clarity, and completeness of the journal or case record.
Ask students how they would approach a similar case in a practical setting.
Marks Distribution-
1. Pose direct questions about different instruments, their uses, and maintenance.
2. Ask students to identify instruments from a set. This can be done visually or
through touch if the exam format allows.
6. Select minimum two instruments each from Ear examination and surgery ,
Nose Examination and surgery, Throat(pharynx and larynx) examination and
surgery.
2. Present clinical scenarios relevant to ENT and ask the student which X-ray
views or types would be most appropriate for diagnosis. Assess their ability to
justify their choices based on the clinical context.
3. Provide students with sample X-rays to interpret. Evaluate their ability to detect
common ENT conditions such as sinusitis, laryngeal masses, mastoiditis, foreign
bodies, and fractures of the nasal bones.
4. Provide minimum one Xray each for Ear and Mastoid; Nose; Paranasal
Sinuses; Pharynx and Larynx.
Ask core questions on the anatomy and physiology of Netra, Karna, Nasa,Mukha
Mark Distribution-
A) Netraroga- 10 marks.
B) Karnaroga- 05 marks.
C) Nasaroga- 05 marks.
D) Mukharoga- 05 marks.
E) Shiroroga- 05 marks.
7 Internal assessment. 30